Concepedia

Chaeyoung Kim

CK

3

Publications

128

Citations

3

H-Index

2023

Active since

Affiliations

Denali Therapeutics (United States)(Current)

Ionis Pharmaceuticals (United States)

Chaeyoung Kim is an author at Denali Therapeutics (United States) specializing in therapeutics, neuroimmunology, and cell transplantation.

ORCID

Top concepts

Publications per year

2023–2024

3

Publications

3

Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · Science Translational Medicine · 2024 · 93 citations

Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · 2023 · 24 citations · Full text

, , +21

SARM1 is responsible for calpain-dependent dendrite degeneration in mouse hippocampal neurons

Takashi Miyamoto, Chaeyoung Kim, Johann Chow et al. · Journal of Biological Chemistry · 2024 · 11 citations · Full text

Rows per page

1–3 of 3